Cardiovascular Event Risks Associated With Masked Nocturnal Hypertension Defined by Home Blood Pressure Monitoring in the J-HOP Nocturnal Blood Pressure Study.

Hypertension
Takeshi FujiwaraKazuomi Kario

Abstract

There is no information regarding the potential association between cardiovascular disease (CVD) event risks and masked nocturnal hypertension defined by home blood pressure (BP) monitoring. We sought to examine this association in a general practice population. For this purpose, we used data from the J-HOP (Japan Morning Surge-Home Blood Pressure) Nocturnal BP Study, which recruited 2745 high-cardiovascular-risk participants (mean [SD] age, 63.6 [10.4] years; 48.7% men; 82.7% on antihypertensive medications). Nocturnal home BPs (HBPs) were measured at 2:00, 3:00, and 4:00 AM using a validated, automated HBP device for 14 consecutive days. The average (SD) of nocturnal HBP measures was 17.1 (13.5). The percentages of participants with controlled BP (nocturnal HBP <120/70 mm Hg and average morning and evening BP <135/85 mm Hg), daytime hypertension (nocturnal HBP <120/70 mm Hg and average morning and evening BP ≥135/85 mm Hg), masked nocturnal hypertension (nocturnal HBP ≥120/70 mm Hg and average morning and evening BP <135/85 mm Hg), and sustained hypertension (nocturnal HBP ≥120/70 mm Hg and average morning and evening BP ≥135/85 mm Hg) were 31.7%, 7.9%, 26.7%, and 33.7%, respectively. During a median 7.6-year follow-up (19 51...Continue Reading

References

Sep 18, 2002·JAMA : the Journal of the American Medical Association·Sharon E StrausFinlay A McAlister
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Nov 19, 2003·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yutaka ImaiUNKNOWN Japanese Society of Hypertension
Mar 18, 2004·JAMA : the Journal of the American Medical Association·Guillaume BobrieJean-Michel Mallion
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
Apr 3, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Seiichi MatsuoUNKNOWN Collaborators developing the Japanese equation for estimated GFR
Jun 4, 2010·Journal of Hypertension·Hong-Qi FanUNKNOWN International Database on Ambulatory Blood Pressure In Relation to Cardiovascular Outcomes Investigators
Apr 19, 2013·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yutaka ImaiTakayoshi Ohkubo
Feb 19, 2014·Hypertension·Yan LiUNKNOWN International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) Investigators*
Apr 8, 2014·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kazuaki ShimamotoUNKNOWN Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension
Aug 19, 2014·Lancet·UNKNOWN Blood Pressure Lowering Treatment Trialists' Collaboration
Apr 24, 2015·American Journal of Hypertension·Marwah AbdallaDaichi Shimbo
Oct 30, 2016·Journal of the American Heart Association·Cheng WangTanqi Lou
May 2, 2018·Hypertension·Kazuomi Kario
Aug 31, 2018·European Heart Journal·Bryan WilliamsUNKNOWN ESC Scientific Document Group
Aug 4, 2019·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Satoshi UmemuraNobuhito Hirawa

❮ Previous
Next ❯

Citations

Aug 8, 2020·American Journal of Hypertension·Daisuke SuzukiKazuomi Kario
Jan 27, 2021·The Journal of Clinical Hypertension·Takeshi FujiwaraKazuomi Kario
Feb 17, 2021·The Journal of Clinical Hypertension·Takeshi FujiwaraKazuomi Kario
Nov 28, 2020·American Journal of Hypertension·Keisuke NaritaKazuomi Kario
Aug 1, 2021·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kazuomi KarioHiroshi Kanegae
Jul 17, 2021·Journal of Hypertension·Gianfranco ParatiUNKNOWN Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension
Aug 26, 2021·American Journal of Hypertension·Kazuomi Kario
Oct 16, 2021·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kazuomi KarioSatoru Yamakawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Risk Reduction

Prevention of cardiovascular disease is an important health initiative. Risk reduction including physical activity, smoking cessation, diet, blood pressure lowering drugs and pharmacotherapy. Here is the latest research on cardiovascular risk reduction.